文献速递糖尿病

2型糖尿病家族史作为1型糖尿病临床异质性分层的重要指标

Type 2 Diabetes Family History as a Significant Index on the Clinical Heterogeneity Differentiation in Type 1 Diabetes.
PubMed 文献 · J Clin Endocrinol Metab · 2023-01-01

前瞻性纳入1410例1型糖尿病患者,10%(141/1410)有一级亲属2型糖尿病家族史,该组起病年龄更大、BMI更高、空腹及餐后C肽更高、胰岛自身抗体阳性率更低且HLA易感基因型更少,分层后异质性一致,聚类分析可分5组且2型糖尿病家族史组表型更轻。

要点

  • 10%(141/1410)的1型糖尿病患者至少1名一级亲属患2型糖尿病。
  • 有2型糖尿病家族史者起病年龄更大、BMI与C肽更高、胰岛自身抗体阳性率与HLA易感基因型更低。
  • 按自身免疫、起病年龄和HLA分层后,2型糖尿病家族史相关临床异质性保持一致。

核心结论

  • 作者认为2型糖尿病家族史应作为基于临床异质性对1型糖尿病患者进行精准亚分类的重要指标。

研究设计与样本

  • 前瞻性研究纳入1410例1型糖尿病患者,由研究护士用半结构化问卷收集一级亲属2型糖尿病家族史。
  • 在整体及按胰岛自身抗体、起病年龄和HLA基因型分层的亚组中评估2型糖尿病家族史对临床特征的影响。
  • 采用聚类分析识别与2型糖尿病家族史相关的亚组。

主要发现

  • 10%(141/1410)的患者至少有1名一级亲属诊断为2型糖尿病。
  • 整体1型糖尿病患者中,有2型糖尿病家族史者表型更轻,包括起病年龄更大(P < .001)、体重指数更高(P < .001)、空腹及餐后C肽水平更高(均P < .01)、所有胰岛自身抗体阳性率更低及易感HLA基因型更少(均P < .05)。
  • 按自身免疫、起病年龄和HLA基因型分层的1型糖尿病亚组中,2型糖尿病家族史相关的临床异质性保持一致。
  • 以2型糖尿病家族史作为聚类变量将1型糖尿病患者分为5个聚类,2型糖尿病家族史聚类组患者表型较其他组更轻。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Family history of type 2 diabetes (T2D) is an important but neglected parameter; however, its role in identifying the heterogeneity and subtypes of type 1 diabetes (T1D) remains unclear. OBJECTIVE: We investigated the effect of family history of T2D on the clinical phenotype of T1D patients and evaluated its value in T1D classification. METHODS: A total of 1410 T1D patients were enrolled in this prospective study. Information on family history of T2D in first-degree relatives (FDRs) was collected by research nurses using a semi-structured questionnaire as previously described. The effect of family history of T2D on clinical characteristics was evaluated in overall and subgroups of T1D patients stratified by islet autoantibodies, onset age, and human leukocyte antigen (HLA) genotype. Cluster analysis was performed to identify family history of T2D-related subgroups. RESULTS: A total of 10% (141/1410) of patients had at least 1 FDR diagnosed with T2D. A milder phenotype associated with family history of T2D was present in overall T1D patients, including older onset age (P < .001), higher body mass index (P < .001), higher fasting and postprandial C-peptide levels (all P < .01), lower positive rates of all islet autoantibodies, and susceptible HLA genotypes (all P < .05). Clinical heterogeneity associated with family history of T2D in the T1D subgroup stratified by autoimmunity, age of onset, and HLA genotypes was consistent. Using family history of T2D as a cluster variable, T1D patients were divided into 5 clusters, and patients in the T2D family history cluster displayed a milder phenotype than others. CONCLUSION: Family history of T2D should be considered as an important indicator for precise subclassification of T1D patients based on clinical heterogeneity.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Wang Q, Chen Y, Xie Y, et al. Type 2 Diabetes Family History as a Significant Index on the Clinical Heterogeneity Differentiation in Type 1 Diabetes. J Clin Endocrinol Metab. 2023. PMID: 37319368. doi:10.1210/clinem/dgad363

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。